No picture, placeholder image
No picture, placeholder image
Institutt for samfunnsmedisin hans.o.melberg@uit.no +4777649162 Tromsø MH L10.146

Melberg, Hans Olav


Professor


  • Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen :
    A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
    BMC Cardiovascular Disorders 2022 ARKIV / DOI
  • Mirabella Zhao, Sandre Svatun Lirhus, Mikael Lördal, Ebbe Langholz, Torben Knudsen, Markku Voutilainen m.fl.:
    Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway
    Alimentary Pharmacology and Therapeutics 2022 DOI
  • Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen :
    Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020
    ESC Heart Failure 2022 ARKIV / DOI
  • Christoffer Bugge, Stein Kaasa, Erik Magnus Sæther, Hans Olav Melberg, Ivar Sønbø Kristiansen :
    What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
    BMJ Open 2021 DOI
  • Snorre Kverndokk, Hans Olav Melberg :
    Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
    European Journal of Health Economics 2021 OMTALE / DOI
  • Karoline Anisdahl, Sandre Svatun Lirhus, Asle Wilhelm Medhus, Bjørn Moum, Hans Olav Melberg, Marte Lie Høivik :
    First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
    Scandinavian Journal of Gastroenterology 2021 ARKIV / DOI
  • Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Karoline Anisdahl, Hans Olav Melberg :
    Incidence and prevalence of inflammatory bowel disease in norway and the impact of different case definitions: A nationwide registry study
    Clinical Epidemiology 2021 ARKIV / DOI
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
    Therapeutic Advances in Gastroenterology 2021 ARKIV / DOI
  • Kristina Malene Ødegaard, Jonas Hallen, Sandre Svatun Lirhus, Hans Olav Melberg, Sigrun Halvorsen :
    Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013-2016
    ESC Heart Failure 2020 ARKIV / DOI
  • Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg :
    Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis
    Hepatology 2019 DOI
  • Hans Olav Melberg, Lars Asphaug :
    Health Economics and Fatty Liver Disease
    Springer Nature 2019 DOI
  • Lars Asphaug, Hans Olav Melberg :
    The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
    Medical Decision Making Policy & Practice 2019 DOI
  • Camilla Beck Olsen, Hans Olav Melberg :
    Did adolescents in Norway respond to the elimination of copayments for general practitioner services?
    Health Economics 2018 ARKIV / DOI
  • Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Hans Olav Melberg :
    Regional differences in anti-TNF-a therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study
    Scandinavian Journal of Gastroenterology 2018 ARKIV / DOI
  • Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg :
    Cost analysis of mobile radiography services for nursing home residents in Southeast Norway
    Journal of Evaluation In Clinical Practice 2018 ARKIV / DOI
  • Hans Olav Melberg :
    Samhandlingsreformen og kausal inferens
    Michael quarterly. Supplement 2017 ARKIV
  • Jan Blomqvist, Raitasalo Kirsimarja, Hans Olav Melberg, Dirk Schreckenberg, Christine Peschel, Justyna klingemann m.fl.:
    Popular images of addiction in five European countries
    Oxford University Press 2016 DOI
  • Trygve Ottersen, Reidun Førde, Meetali Kakad, Alice Kjellevold, Hans Olav Melberg, Atle Moen m.fl.:
    A new proposal for priority setting in Norway: Open and fair
    Health Policy 2016 DOI
  • Justin E. Bekelman, Scott D. Halpern, Carl Rudolf Blankart, Julie P. Bynum, Joachim Cohen, Robert Fowler m.fl.:
    Comparison of site of death, health care utilization, and hospital expenditures for patients dying With cancer in 7 developed countries
    Journal of the American Medical Association (JAMA) 2016 DOI
  • Camilla Beck Olsen, Hans Olav Melberg :
    Påvirker egenandeler ungdoms legebesøk?
    Tidsskrift for velferdsforskning 2016 ARKIV / DOI
  • Hans Olav Melberg, Camilla Beck Olsen, Kine Pedersen :
    Did hospitals respond to changes in weights of Diagnosis Related Groups in Norway between 2006 and 2013?
    Health Policy 2016 DOI
  • Terje P. Hagen, Hans Olav Melberg :
    Liggetider og reinnleggelser før og etter Samhandlingsreformen.
    Tidsskrift for omsorgsforskning 2016 DOI
  • Hans Olav Melberg, Ida Eriksen :
    The effects of introducing an electronic prescription system with no copayments
    Health Economics Review 2015 DOI
  • Emma Medin, Fanny Goude, Hans Olav Melberg, Fabrizio Tediosi, Eva Belicza, Mikko Peltola :
    European regional differences in all-cause mortality and length of stay for patients with hip fracture
    Health Economics 2015 DOI
  • Ida Eriksen, Hans Olav Melberg :
    Endringer over tid i legers holdninger til kostnader
    Akademika forlag 2014
  • Steinar Holden, Oona Borghild Dunlop, Styrk Fjærtoft Vik, Ingrid Hjort, Simen Markussen, Hans Olav Melberg m.fl.:
    Holden-IV (covid-19) Hovedrapport: Samfunnsøkonomiske vurderinger av smitteverntiltak
    2022
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    Forskjeller i medikamentoverlevelse mellom perorale mesalazin-preparater som monoterapi ved ulcerøs colitt
    2020
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis
    Journal of Crohn's and Colitis 2020 DOI
  • Linda Hildegard Bergersen, Aasta Marie Bjorvand Bjørkøy, Evandro Fei Fang, Olav Gjelsvik, Lene Hystad Hove, Janicke Liaaen Jensen m.fl.:
    Vi må kunne tenke nytt om alderdom
    2020 FULLTEKST / DATA
  • Tore Tennøe, Hilde Lovett, Erik Fosse, Siri B Hatlen, Steinar Madsen, Damoun Nassehi m.fl.:
    Kunstig Intelligens og Norske Helsedata
    2019
  • Hans Olav Melberg :
    Value in health: How it is defined and used in priority setting and pricing in Norway
    HealthcarePapers 2019 DOI
  • Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg :
    Radiography on wheels for nursing home residents may reduce healthcare costs
    2018
  • Hilde Lovett, Damoun Nassehi, Erik Fosse, Siri B Hatlen, Steinar Madsen, Hans Olav Melberg m.fl.:
    Kunstig Intelligens - Muligheter, Utfordringer og en Plan for Norge
    2018
  • Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl m.fl.:
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplantation 2018 DOI
  • Hans Olav Melberg :
    Helse-Norge trenger tvil – ikke bare heiarop
    Dagens medisin 09. mars 2018
  • Hans Olav Melberg :
    Obama-reformen – og norsk helsepolitikk
    Dagens medisin 05. mai 2018
  • Hans Olav Melberg :
    Hvorfor koster diamanter mer enn vann?
    Dagens medisin 2018
  • Hans Olav Melberg :
    Registertilgang i molboland?
    Dagens medisin 2018
  • Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl m.fl.:
    Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009: Cost-utility and survival in children and young adults
    2017
  • Hans Olav Melberg :
    Skal det være en app –eller to?
    Dagens medisin 18. januar 2016
  • Hans Olav Melberg :
    Medisiner i ingenmannsland – mens tiden går…
    Dagens medisin 18. april 2016
  • Hilde Lovett, Tore Tennøe, Ola Dale, Nils Jørgen Langtvedt, Hans Olav Melberg, Steinar Madsen m.fl.:
    Mobile Selvtester
    2016
  • Hans Olav Melberg :
    Helse og finansiering i Norge
    2015
  • Hans Olav Melberg :
    Effekter av politiske reformer: Hvorfor går det ofte galt?
    2015
  • Hans Olav Melberg :
    Bruker vi de store pengene på de største problemene?
    2015
  • Hans Olav Melberg :
    Hellig helse - og prislapp på slutten av livet?
    Dagens medisin 10. mars 2014 FULLTEKST
  • Hans Olav Melberg :
    Statsbudsjettet: Raskere og mer private symfonier
    Dagens medisin 27. oktober 2014 FULLTEKST
  • Hans Olav Melberg :
    Nye regler for prioritering
    2014
  • Hans Olav Melberg :
    Jordbær, finansiering - og informasjon i norsk helsevesen
    Dagens medisin 08. september 2014 FULLTEKST
  • Hans Olav Melberg :
    Struts, sykehjem og søppel?
    Dagens medisin 23. mai 2014 DATA

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →